# Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]

> **NCT04178993** · PHASE1 · COMPLETED · sponsor: **Craig Rush** · enrollment: 8 (actual)

## Conditions studied

- Methamphetamine Use Disorder

## Interventions

- **DRUG:** Methamphetamine
- **DRUG:** Methylphenidate
- **DRUG:** Placebo oral capsule
- **DRUG:** Duloxetine

## Key facts

- **NCT ID:** NCT04178993
- **Lead sponsor:** Craig Rush
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-01
- **Primary completion:** 2021-05-05
- **Final completion:** 2021-05-05
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2023-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04178993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04178993, "Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04178993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*